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Background: Increasing incidence rates of thyroid cancer have been noted worldwide, while the underlying
reasons remain unclear.
Methods: Using data from population-based cancer registries, we examined the time trends of thyroid cancer
incidence in two largest cities in China, Shanghai and Hong Kong, during the periods 1973–2009 and 1983–2011,
respectively. We further performed age-period-cohort analyses to address the possible underlying reasons for the
observed temporal trends.
Results: We observed continuous increases in the incidence rates of thyroid cancer in Shanghai and Hong Kong,
since the 1980s, in addition to higher incidence rates in the 1970s in both sexes in Shanghai. The age-standardized
incidence rate of thyroid cancer increased by 3.1% [95% confidence interval (CI): 1.0%, 5.1%] and 3.8% (95% CI: 1.9%,
5.7%) per year on average, respectively, in Shanghai men and women during the period 1973–2009, while it
increased by 2.2% (95% CI: 1.5%, 2.8%) and 2.7% (1.6%, 3.8%) per year on average, respectively, in Hong Kong men
and women during the period 1983–2011. We observed global changes in trends across all age groups in similar
ways, in addition to varied trends across different generations (birth cohorts).
Conclusions: The increased incidence rates of thyroid cancer in these two Chinese populations during recent
decades may be contributable to a combination of the introduction of more sensitive diagnostic techniques and
the increasing prevalence of environmental exposures in the populations.
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Thyroid cancer is a malignancy that arises from follicular
or parafollicular thyroid cells. A steady increase in the
incidence rate of thyroid cancer has been noted in
recent decades all over the world, especially in women
[1-5]. Previous studies also reported a noteworthy in-
crease in the incidence rate of thyroid cancer in Chinese
populations [6-8]. A upward trend was suggested in
Hong Kong women, jumping from the 12th in 1999 to
5th most common cancer in 2011 [9]. The increasing* Correspondence: shelly@cuhk.edu.hk; cjinquan@szcdc.net
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unless otherwise stated.incidence rates were indicated by the annual percentage
change (APC) of 14.4% and 19.9% in men and women,
respectively, in Shanghai since the early 2000s [6].
One possible explanation for the observed increase in
the incidence rate of thyroid cancer may be the more
frequent use of sensitive diagnostic procedures, such as
ultrasound, Doppler examination, CT and MRI scanning,
and biochemical markers, during recent decades, which
may have increased the detection of thyroid cancers
[10,11]. On the hand, it is also possible attributable to
the increasing prevalence of environmental risk factors
for thyroid cancer in the population, which was sup-
ported by the fact that the increase of thyroid cancer
incidence was not restricted to small tumors only [1,12].
Overall, the underlying causes for the worldwide increases is an Open Access article distributed under the terms of the Creative
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likely to be multifactorial.
Age-period-cohort analysis is a helpful tool for inter-
pretation of observed temporal trends in disease rates
over time, which attempts to sort out the effects of age,
calendar period, and birth cohort on disease rates by
fitting statistical regression models. Changes in observed
disease rate over time in vital registries may be affected
by artifacts that alter the estimates of disease rates, such
as changes in definition of diseases, improved complete-
ness and quality of reporting systems, and utilization of
more frequent and sensitive diagnostic techniques,
which may not necessarily indicate true underlying
disease burden. In such cases, we would observe a global
change in trends that affects the rates across all age
groups in a similar way, which is referred to as “period
effect”. Temporal changes in disease rates associated
with environmental and biological risk factors usually
vary across different generations (birth cohorts) being
exposed to different exposures, and are known as
“cohort effect” [13,14].
To better understand the temporal trends in the
incidence rates of thyroid cancer and the underlying
reasons, we examined the time trends of thyroid cancer
incidence in two largest cities in China, Shanghai and
Hong Kong, during the periods 1973–2009 and 1983–
2011, respectively. We further performed age-period-
cohort analyses to address the effects of birth cohort
and calendar period on the observed temporal trends
using a newly developed statistical web tool [15]. Etio-
logical implications were also considered with reference
to possible environmental risk factors.Figure 1 Time trends of thyroid cancer incidence rates. Age-standardiz
1973–2009 and in Hong Kong during 1983–2011, respectively, using WHOMethods
We obtained the age- and sex- specific data on all newly
diagnosed thyroid cancer cases in Shanghai during 1973–
2009 and in Hong Kong during 1983–2011 from Shanghai
Cancer Registry and Hong Kong Cancer Registry, respec-
tively. Cancer incidence data from these two population-
based cancer registries have been included in the Cancer
Incidence in Five Continents series since the 1970s.
Age- and sex-specific population data were from Shanghai
Municipal Public Security Bureau and the Hong Kong gov-
ernment Census and Statistics Department, respectively.
Age-standardized annual incidence rates were cal-
culated by the direct method using the WHO World
Standard Population (1966) as the reference. We used
Joinpoint Regression Program developed by US National
Cancer Institute (NCI) which identified changing points
of the trend and estimate the Annual Percentage Change
(APC), under the assumption that the rate changed at a
constant percentage every year change linearly on a
log scale, for each time segment. The Average Annual
Percent Change (AAPC), a weighted average of APCs
from the joinpint models with weights equal to the
length of the APC interval, was also computed as a sum-
mary measure of the trend over the whole observation
period [16].
We further performed age-period-cohort regression for
each gender to examine the age, period and cohort effects
the on incidence rates of thyroid cancer using a web tool
for age-period-cohort analysis, which was newly deve-
loped by the US NCI [15]. This online web tool can pro-
vide the longitudinal age curve in the disease rates which
is a smoothing summary curve from observed cohort-ed incidence rates of thyroid cancer by sex in Shanghai during
World Standard Population 1966 as the reference.
Table 1 Time trends of age-standardized incidence rates
Population Calendar period APC (95% CI)
Shanghai, men 1973-1976 17.1 (−0.6, 38.0)
1976-1982 −16.7 (−22.6, −10.3)*
1982-2000 2.9 (1.8, 4.1)*
2000-2009 14.0 (10.7, 17.5)*
Full period AAPC (95% CI) = 3.1
(1.0, 5.1)*
Shanghai, women 1973-1975 16.9 (−10.8, 53.1)
1975-1983 −13.2 (−16.3, −10.0)*
1983-2002 5.3 (4.4, 6.2)*
2002-2009 18.4 (14.2, 22.7)*
Full period AAPC (95% CI) = 3.8
(1.9, 5.7)*
Hong Kong, men 1983-2011 2.2 (1.5, 2.8)*
Full period AAPC (95% CI) = 2.2
(1.5, 2.8)*
Hong Kong, women 1983-1989 6.8 (2.6, 11.2)*
1989-2003 −0.1 (−1.0, 0.9)
2003-2011 4.6 (2.9, 6.4)*
Full period AAPC (95% CI) = 2.7
(1.6, 3.8)*
*Significantly different from zero at α = 0.05; AAPC: Average Annual Percent
Change; APC: Annual Percent Change; CI: Confidence Interval.
Time trends in age-standardized incidence rates of thyroid cancer by sex in
Shanghai during 1973–2009 and in Hong Kong during 1983–2011.
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age-specific rates derived from cross-sectional data for un-
derstanding the age pattern of disease risk. The APCs for
each age group, called “local drifts”, can be generated from
log-linear regressions. The web tool can also calculate the
relative rate in any given calendar period (or birth cohort)
versus a referent period (or birth cohort), adjusted for age
and non-linear cohort (or period) effects. The central age
group, period, and birth cohort were defined as the refer-
ence, respectively, in all age-period-cohort analyses. In
case of an even number of categories, the reference value
was set as the lower of the two central values. Since we
only have access to incidence data by 5-year age groups,
were used the same 5-year intervals for calendar periods
and birth cohorts, so the age-period-cohort analyses were
only performed in periods of multiplies of 5, during 1973–
2007 in Shanghai and during 1987–2011 in Hong Kong,
respectively.
This study was performed with the approval from
the Ethics Committee of Shenzhen Center for Disease
Prevention and Control and in compliance with the
Helsinki Declaration. No information to identify indivi-
dual subjects was included in the study.
Results
There were 3449 men and 11252 women, and 2457 men
and 8862 women who were diagnosed with thyroid can-
cer in Shanghai during 1973–2009, and in Hong Kong
during 1983–2011, respectively. The time trends of inci-
dence rates of thyroid cancer by sex in Shanghai and
Hong Kong are shown in Figure 1. The thyroid cancer
incidence was female predominant in both populations,
with the female to male ratio in age-standardized rate
ranged from 1.9 to 4.5 in Shanghai and from 2.6 to 5.0
in Hong Kong across calendar years. The incidence rates
of thyroid cancer in both men and women in Shanghai
changed in similar patterns during the period 1973–
2009. The thyroid cancer incidence decreased in men
during the period 1976–1982 and in women during the
period 1975–1983, followed by a slight but significant
rise in men during the period 1982–2000 and in women
during the period 1983–2002, and dramatically increased
thereafter. We also observed increased, though not sta-
tistically significant, incidence rates in Shanghai men
during the period 1973–1976 and in Shanghai women
during the period 1973–1975. During the period 1973–
2009, the overall AAPCs of the incidence rates in Shang-
hai men was 3.1% [95% confidence interval (CI): 1.0%,
5.1%] and it was 3.8% (95% CI: 1.9%, 5.7%) in women.
The incidence rate of thyroid cancer among Hong Kong
men steadily increased from 1983 to 2011 with a full-
period AAPC of 2.2% (95% CI: 1.5%, 2.8%). We observed
significant increases in the incidence rate in Hong Kong
women during two periods of 1983–1989 and 2003–2011, whereas it remained stable during the period
1983–2003. The full-period AAPC in the incidence rate
among Hong Kong women was 2.7% (1.6%, 3.8%). The
APCs for specific period segments by sex in these two
populations are presented in Table 1.
The longitudinal age curves of thyroid cancer inci-
dence by sex in Shanghai and Hong Kong were illus-
trated in Figure 2. The risk of thyroid cancer increased
monotonically in men in both populations except for
minor decreases at old ages (75 years and above), which
might be explained by competing risk from deaths. The
longitudinal age curve in women in Shanghai displays
the similar overall pattern as men, though with a minor
peak at the ages 45–49. The risk in Hong Kong women
increased with age until peaking at ages 55–64 years and
showed a decline thereafter.
The local drift values, which indicate the APCs in the
incidence rates during the study periods, by sex for spe-
cific age groups in the two populations are displayed in
Figure 3. We observed local drift values above 0 in all
age groups in both sexes in Shanghai, which were higher
at ages 20–39 years and above 70 years in men and
increased with age with a minor peak around the age of
50 years in women. The local drift values varied greatly
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most were above 0 only with a few insignificant excep-
tions at the oldest or youngest age groups. We observed
dramatically elevated local drift values at ages 30–44 years
in men and 35–44 years in women in the Hong Kong
population.
The estimated period and cohort effects by sex in the
two populations are displayed in Figures 4 and 5, re-
spectively. We observed period effects in similar patterns
for both sexes in Shanghai, which shifted downwards
since the period of 1973–1977 and then turned upwards
since early 1990s with a significantly elevated risk for the
periods after early 2000s in men and the periods after
mid-1990s in women. The period effects remained
relatively stable in both sexes in Hong Kong but yielded
significantly elevated increases for the most recent
period 2007–2011. The risk of thyroid cancer increased,
in general, with birth cohort in both sexes in Shanghai.
The cohort effects remained stable for the first several
birth cohorts, followed by upwards inflection for men
and women born after mid-1940s.
Wald tests suggested statistically significant cohort and
period effects for both populations (P < 0.05 for all). TheFigure 2 Longitudinal age curves of thyroid cancer incidence rates. L
cancer and the corresponding 95% confidence intervals by sex in Shanghalocal drifts were statistically significant for both sexes in
Hong Kong (P < 0.05 for both) but not significant in
Shanghai (P = 0.376 for men, and P = 0.126 for women).
Discussion
A worldwide upwards trend in the incidence rate of thy-
roid cancer has been documented in recent decades. In
this study, we have described continuous increase in the
incidence rate of thyroid cancer since early 1980s in two
Chinese populations, in Shanghai and Hong Kong. We
also observed relatively higher incidence rate during the
period of early 1970s to early 1980s in both sexes in
Shanghai. The increased incidence rate across popu-
lations in certain periods may be, at least partially,
explained by the use of sensitive diagnostic procedures,
such as the introduction of ultrasound examination in the
1970s in China and more sensitive imaging techniques
(e.g. CT, MRI and PET scan) in recent years. Such specu-
lations were also supported by the observed period effects
in the age-period-cohort analyses. The increasing inci-
dence rate would be more likely to be explained by period
effects in Shanghai, given the similar changes across age
groups as indicated by non-significant local drift values.ongitudinal age curves of the incidence rates (1/100 000) of thyroid
i and Hong Kong.
Figure 3 Local drift values for thyroid cancer incidence rates. Age group specific annual percent change (%) in the incidence rates of thyroid
cancer and the corresponding 95% confidence intervals by sex in Shanghai and Hong Kong.
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dence may also suggest a true increase in the risk of
thyroid cancer in the populations, as the magnitude of
changes over time varied across age groups and the esti-
mated cohort effects increased for recent birth cohorts.
The etiology of thyroid cancer has not been com-
pletely understood till now, whereas ionizing radiation
exposure is the only unequivocally established en-
vironmental risk factor for thyroid cancer [17,18]. A
continuous increase in the frequency of medical diag-
nostic and therapeutic nuclear medicine procedures in
Shanghai has been described during the 12 years be-
fore 2008, and the annual individual radiation dose due
to medical procedures had doubled [19]. A survey by
Hong Kong Census and Statistic Department in 2008
found that around 17% of the population aged 15 years
and above had medical checkup regularly, among which
68% had medical checkups taken once every 7 to
12 months and one third of the checkups included
X-rays [20]. More frequent use of nuclear medical pro-
cedures may have resulted in increased exposures to
radiation, and thus, have contributed to the increased
incidence of thyroid cancer.Our study confirmed the female predominance in the
incidence rate of thyroid cancer and also observed a
downward inflection in the age curve of thyroid cancer
risk after menopausal ages in women, which suggest a
pivotal role of oestrogen in the development of thyroid
cancer [21]. Oestrogen as a risk factor for thyroid cancer
was also supported by experimental studies showing that
oestrogen was a potent simulator of both human benign
and malignant thyroid cells [22,23]. If such hypothesis is
confirmed with further evidence, the increasing inci-
dence of thyroid cancer would be possible to be ex-
plained, to some extent, by the exposure to endocrine
disrupting chemicals (EDCs) in the population [24,25].
Epidemiological evidence concerning iodine intake
and thyroid cancer risk remains largely lacking and
controversial. Previous case–control studies reported
statistically non-significant increased thyroid cancer risk
associated with higher dietary intake of iodine [26,27],
while inverse associations between dietary iodine intake
and thyroid cancer risk were observed in others [28,29].
China introduced universal salt iodization in 1995 to
reduce the prevalence of iodine deficiency in Mainland
China [30], while no iodine supplementation program
Figure 4 Period effects on thyroid cancer incidence rates. Period effects obtained from age-period-cohort analyses for the incidence rates of
thyroid cancer and the corresponding 95% confidence intervals by sex in Shanghai and Hong Kong.
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increasing in thyroid cancer incidence in Shanghai since
the early 2000s, around 5–7 years after the implemen-
tation of the universal salt iodination, but there was no
commensurate marked increase in cohort effects in the
age-period-cohort analysis. Thus, our results did not
reveal a clear association between the salt iodination
program and thyroid cancer risk in the population in
Shanghai, which still needs to be clarified in analytic
epidemiological studies.
Previous studies have indicated a higher risk of thyroid
cancer in individuals with a higher socioeconomic status
[31,32]. Such observations may be explained by the in-
creased medical radiation exposure and diet with more
energy intake, which may in turn, lead to elevated body
mass and consequently increased risk of thyroid cancer
[33]. Our findings suggested those born after mid-1945s
had increased risk of thyroid cancer, which might be
linked to the improved living conditions and nutrition in
the populations after the World War II. The increasing
incidence rates of thyroid cancer may also be attri-
butable to the increasing prevalence of other potential
risk factors, particularly exposures to environmentalcarcinogens, in the populations during recent decades.
The candidate exposures may include, but not restricted
to, EDCs, nitrite and nitrate ingested through drinking
water, solvents, and metals [18,34]. Nevertheless, con-
firmation of the possible causal relationships between
environmental pollutants and thyroid cancer still war-
rants more epidemiological investigations in the future.
Since different histological types of thyroid cancer may
not be necessarily etiologically homogenous, the chan-
ging epidemiology of thyroid cancer may have varied
across histological types due to the possible distinct tem-
poral trends in the prevalence of specific risk factors in
the populations. Reports from other populations have
indicated that the increasing incidence rate of thyroid
cancer was mostly in that of papillary thyroid cancer
[35,36]. However, we were not able to perform sub-
group analyses on the time trends in the incidence rate
of thyroid cancer due to lack of information on histo-
logical types, which would be a major limitation of this
study. In addition, although we attempted to sort out
the effects of birth cohorts and calendar periods on the
observed trends in the incidence rates of thyroid cancer
after adjustment for age, all etiological interpretations
Figure 5 Cohort effects on thyroid cancer incidence rates. Cohort effects obtained from age-period-cohort analyses for the incidence rates of
thyroid cancer and the corresponding 95% confidence intervals by sex in Shanghai and Hong Kong.
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herent limitations of age-period -cohort analysis, such
as collinearity among age, period and cohort effects.
Furthermore, all time trends analyses on disease rates
in this study were ecological descriptive analyses at
population levels without inference at individual levels.
This study was inevitably subject to ecological fallacy,
since interpretations from results at population levels
do not necessarily hold for individuals. Therefore, all
hypotheses raised in this study still need further
confirmation in analytic epidemiological studies.
Conclusions
In summary, we observed continuous increases in the
incidence rates of thyroid cancer in two Chinese popula-
tions, in Shanghai and Hong Kong, since the 1980s, in
addition to higher incidence rates in the 1970s in both
sexes in Shanghai. The increased incidence rates of thy-
roid cancer in these two Chinese populations during re-
cent decades may be contributable to a combination of
the introduction of more sensitive diagnostic techniques
and the increasing prevalence of environmental expo-
sures in the populations. More analytic epidemiologicalstudies are warranted to clarify the underlying reasons
for the increasing incidence rate of thyroid cancer and
the causes of thyroid cancer.Competing interests
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